Projects per year
Search results
-
Finished
-
MT2018-07 A Multi-Center Phase 2 Study of Combined Modality Treatment with Ruxolitinib, Decitabine, and Donor Lymphocyte Infusion for Post-Transplant Relapse of AML or MDS
Juckett, M. B. (PI) & Rashidi, A. (Prior Principal Investigator)
1/31/19 → 9/30/24
Project: Research project
-
CD16/IL-15/CD33 (161533) Tri specific Killer Engagers (TriKEs) for the Treatment of High Risk Myelodysplastic Syndromes, Refractory/Relapsed Acute Myeloid Leukemia and Advanced Systemic Mastocytosis
Juckett, M. B. (PI) & Warlick, E. D. (Prior Principal Investigator)
6/1/17 → 1/31/24
Project: Research project